Chongqing Zhifei Biological Products Co., Ltd.

Chongqing Zhifei Biological Products Co., Ltd. faced a notable decline in its stock today, contrasting with broader market trends. The company has experienced significant losses over various time frames, including a 36.78% year-to-date drop and an 82.1% decline over the past three years, amid ongoing profitability challenges.

Chongqing Zhifei Biological Products Co., Ltd. faced a notable decline in stock performance, continuing a trend of underperformance with a significant annual decrease. The company has reported negative operating profits and sales growth, alongside six consecutive quarters of losses, raising concerns about its financial health and market position.

Chongqing Zhifei Biological Products Co., Ltd. faced a significant decline in stock value, reflecting ongoing challenges over the past year. The company has reported negative operating profit and six consecutive quarters of losses, with a market capitalization of CNY 24,007 million and a negative return on equity.

Chongqing Zhifei Biological Products Co., Ltd. experienced a notable intraday gain, contrasting with the modest rise of the China Shanghai Composite. However, the company has struggled over the past year, with significant declines in net sales and operating profit, alongside ongoing negative quarterly results and financial challenges.

Chongqing Zhifei Biological Products Co., Ltd. has faced significant stock declines, with a notable drop today. The company has reported substantial decreases in net sales and profit, reflecting ongoing challenges in the pharmaceuticals and biotechnology sector, alongside a concerning long-term performance trend.